AzTrials
AzTrials

Low Back PainNCT04191317

Pain Neuroscience Education and Gradual Exposure to Exercise in Factory Workers With Chronic Low Back Pain

A study testing Pain Neuroscience Education and gradual exposure and Pilates and postural education in people with Low Back Pain, run by Aveiro University at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to compare the effectiveness of a pain neuroscience education (PNE) based programe and gradual exposure to exercise versus pilates on disability levels associated with chronic low back pain in factory workers. There will be two arms each one receiving one type of intervention over 8 weeks. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Low Back Pain
What is being tested?
Pain Neuroscience Education and gradual exposure and Pilates and postural education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
37 participants
Where
1 sitePortugal
Study dates
2 Dec 2019to 30 Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • to have nonspecific low back pain lasting longer than three months, felt in the anatomic region below the costal margin and above the inferior gluteal folds, without referred leg pain and not related to any specific pathology such as lumbar fracture, ankylosing spondylitis, cauda equina syndrome, infection or tumour;
  • not receiving treatment for low back pain.

Who cannot join

  • altered sensorial signs indicative of radiculopathy; red flags such as weight loss without a particular cause, cancer diagnosis or sustained use of corticoids;
  • presence of any rheumatic, neurologic or cardiorespiratory disease that prevent the practice of physical exercise.

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Escola Superior de Saúde

    Aveiro

Other trials in Portugal

About this study

This study aims to compare the effectiveness of a pain neuroscience education (PNE) based programe and gradual exposure to exercise versus pilates on disability levels associated with chronic low back pain in factory workers. There will be two arms each one receiving one type of intervention over 8 weeks.

Read the detailed description

This will be a pilot randomized controlled and experimental study. There will be two groups, one group will receive an intervention strategy based in basic postural re-education exercises (Pilates) and self-management strategies, and the other group will perform a program based in pain neuroscience education and gradual exposure to exercise. Both interventions will be delivered in the physiotherapy office of a paper industry. Participants will be randomly allocated according to the work team they belong, to an intervention arm.

The inclusion criteria to participate in the study are: to have nonspecific low back pain lasting longer than three months, felt in the anatomic region below the costal margin and above the inferior gluteal folds, without referred leg pain and not related to any specific pathology such as lumbar fracture, ankylosing spondylitis, cauda equina syndrome, infection or tumour and not receiving treatment for low back pain. Participants will be excluded if during the physical examination they show altered sensorial signs indicative of radiculopathy; red flags such as weight loss without a particular cause, cancer diagnosis or sustained use of corticoids; presence of any rheumatic, neurologic or cardiorespiratory disease that prevent the practice of physical exercise.

Once inclusion criteria have been ascertained, participants will be assessed for sociodemographic and anthropometric data, pain, disability, knowledge of pain neurophysiology, pain catastrophizing, fear of movement, presence of a neuropathic component, workstation evaluation and global impression of change related to intervention.

The intervention will last for 8 weeks, during which participants will have 1 face-to-face session per week with a duration of approximately 60 minutes each. One group (Pilates group) will receive an intervention based on Pilates' and and postural education. The other group will have theoretical sessions of PNE and gradual exposure to exercise (PNE plus graded exposure group).

Conditions
Low Back Pain
Being tested
Pain Neuroscience Education and gradual exposure, Pilates and postural education
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pain Neuroscience Education and gradual exposureOther

    Education covering the pathophysiology of apin and exercises based on the gradual exposure principle

  • Pilates and postural educationOther

    Postural education and pilates exercises

Study groups in NCT04191317
Study groupRoleWhat they receive
Pain Neuroscience Education and gradual exposureExperimentalEducation explaining the neurophysiological processes that lead to chronic pain, in order to change maladaptive belief towards disease, reconceptualising them and desensitizing the Central Nervous system. On first session of gradual exposure the patients are challenged to create a hierarchically list with the functional activities they experience fear, and exposure begins with the one they have less. Both the therapist and participant will determine a specific group of exercises after the patient understands the benign nature of pain, and will be evaluated the maximal performance of the individual to perform each exercise separately.
Receives: Other: Pain Neuroscience Education and gradual exposure
Pilates and postural educationActive comparatorIn the first session, basic Pilates principles will be taught and reinforced at the beginning of the follow up sessions, including: postural alignment (neutral spine position, shoulder blade and neck position) and core recruitment along with a controlled breathing. Each session will have a warm up, mobility, stability and strengthening exercises and a cool down period.
Receives: Other: Pilates and postural education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Measured using the Numerical Rating Scale (NRS), a 11-point scale is a measure of pain in which patients rate their pain ranging from 0 (no pain) to 10 (worst pain imaginable)

    Measured: Baseline (week 0)

  2. Pain intensity

    Measured using the Numerical Rating Scale (NRS), a 11-point scale is a measure of pain in which patients rate their pain ranging from 0 (no pain) to 10 (worst pain imaginable)

    Measured: End of study - week 9

  3. Pain intensity

    Measured using the Numerical Rating Scale (NRS), a 11-point scale is a measure of pain in which patients rate their pain ranging from 0 (no pain) to 10 (worst pain imaginable)

    Measured: 3 months follow up

Secondary outcomes (18)
  1. Disability

    Measured using the Roland Morris Disability Questionnaire, scored a minimum of 0 and a maximum of 24

    Measured: Baseline (week 0)

  2. Disability

    Measured using the Roland Morris Disability Questionnaire, scored a minimum of 0 and a maximum of 24

    Measured: End of study - week 9

  3. Disability

    Measured using the Roland Morris Disability Questionnaire, scored a minimum of 0 and a maximum of 24

    Measured: 3 months follow up

  4. Knowledge of pain neurophysiology

    Measured using the Neurophysiology of Pain Questionnaire scored a minimum of 0 and a maximum of 19

    Measured: Baseline - week 0

  5. Knowledge of pain neurophysiology

    Measured using the Neurophysiology of Pain Questionnaire scored a minimum of 0 and a maximum of 19

    Measured: End of study - week 9

  6. Knowledge of pain neurophysiology

    Measured using the Neurophysiology of Pain Questionnaire scored a minimum of 0 and a maximum of 19

    Measured: 3 months follow up

  7. Pain catastrophizing

    Measured using the Pain Catastrophizing Scale scored a minimum of 0 and a maximum of 52

    Measured: Baseline - week 0

  8. Pain catastrophizing

    Measured using the Pain Catastrophizing Scale scored a minimum of 0 and a maximum of 52

    Measured: End of study - week 9

  9. Pain catastrophizing

    Measured using the Pain Catastrophizing Scale scored a minimum of 0 and a maximum of 52

    Measured: 3 months follow up

  10. Fear avoidance behavior

    Measured using the Tampa Scale of Kinesiophobia, total score varies from 13 to 52, where 13 represents the less and 52 the greater level of fear of movement

    Measured: Baseline - week 0

  11. Fear avoidance behavior

    Measured using the Tampa Scale of Kinesiophobia, total score varies from 13 to 52, where 13 represents the less and 52 the greater level of fear of movement

    Measured: End of study - week 9

  12. Fear avoidance behavior

    Measured using the Tampa Scale of Kinesiophobia, total score varies from 13 to 52, where 13 represents the less and 52 the greater level of fear of movement

    Measured: 3 months follow up

  13. Pain phenotype

    Measured using the Pain Detect Questionnaire. Total score varies from -1 to 38 points. Scores below 12 indicate little probability of a neuropathic component (85% chance of not having); scores between 12 - 19 reveal a mixed phenotype, whereas a score above 19 reveals high probability of neuropathic pain (90% chance).

    Measured: Baseline - week 0

  14. Pain phenotype

    Measured using the Pain Detect Questionnaire. Total score varies from -1 to 38 points. Scores below 12 indicate little probability of a neuropathic component (85% chance of not having); scores between 12 - 19 reveal a mixed phenotype, whereas a score above 19 reveals high probability of neuropathic pain (90% chance).

    Measured: End of study - week 9

  15. Pain phenotype

    Measured using the Pain Detect Questionnaire. Total score varies from -1 to 38 points. Scores below 12 indicate little probability of a neuropathic component (85% chance of not having); scores between 12 - 19 reveal a mixed phenotype, whereas a score above 19 reveals high probability of neuropathic pain (90% chance).

    Measured: 3 months follow up

  16. Patient Global Impression of Change

    Measured using the Patient Global Impression of Change (PGIC) scale. This is a unidimensional measure widely used in chronic pain studies, in which the patients classify their improvements using a 7-point scale, varying from "1- no change" to "7 - a great deal better and a considerable improvement that has made all the difference"

    Measured: Baseline - week 0

  17. Patient Global Impression of Change

    Measured using the Patient Global Impression of Change (PGIC) scale. This is a unidimensional measure widely used in chronic pain studies, in which the patients classify their improvements using a 7-point scale, varying from "1- no change" to "7 - a great deal better and a considerable improvement that has made all the difference"

    Measured: End of study - week 9

  18. Patient Global Impression of Change

    Measured using the Patient Global Impression of Change (PGIC) scale. This is a unidimensional measure widely used in chronic pain studies, in which the patients classify their improvements using a 7-point scale, varying from "1- no change" to "7 - a great deal better and a considerable improvement that has made all the difference"

    Measured: 3 months follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2019
  2. Study start2 Dec 2019
  3. Primary completion30 Jul 2021
  4. Study completion30 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two arms, each receiving a different intervention.
Masking
None (open label)
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04191317
Sponsor's protocol ID
21-CED/2019
Status last verified
Jul 2022
First submitted
5 Dec 2019
Last updated
15 Jul 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Pain Neuroscience Education and gradual exposure and Pilates and postural education in people with Low Back Pain, run by Aveiro University at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: Baseline (week 0)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in